IRCT20141201020178N11已完成3 期
A comparison between the effect of rifaximin in different doses on symptoms and quality of life improvement in Iranian patients with diarrhea-predominant irritable bowel syndrome, a randomized clinical trial.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 70 years（—）
- 性别
- All
入选标准
- •Diarrhea-dominant IBS (IBS-D) patients
- •Patients who are able to follow the study protocol
- •Patients who are available for the entire study period
- •Women and men amongst Iranian population
- •16-70 years old patients
排除标准
- •All patients with other subclass of IBS
- •Probiotics consumption in the last 3 months
- •Antibiotic therapy in the last 3 months
- •Concomitant systemic disease (malignancy, uncontrolled hypertension, diabetes mellitus, liver, kidney, pulmonary or heart diseases, neurological disorders, psychosis, thyroid dysfunction, lactose intolerance, pregnancy or breastfeeding, inflammatory bowel disease, celiac disease, and gastroduodenal disease)
- •Taking fiber supplements within 2 weeks before starting the study
- •Planning to have surgery during the study time
- •History of alcohol or drug abuse
- •Participating in another clinical trial over the past three months
- •Positive PCR result for covid 19
研究者
相似试验
已完成
3 期
The therapeutic effects of rifaximin in diarrhea-predominant irritable bowel syndromediarrhea-predominant irritable bowel syndrome.K58.0Irritable bowel syndrome with diarrheaIRCT20141201020178N12Iran University of Medical Sciences150
招募中
2 期
Prospective study on suppression of cholangitis using rifaximin after SEMS placement for distal malignant biliary obstructioJPRN-jRCTs051210173Ikezawa Kenji30
进行中（未招募）
1 期
Effect of administration of Rifaximin on the increased portal pressure of patients with liver cirrhosis and esophageal varices already treated with propranololEUCTR2014-000102-35-ITClinica Medica 560
已完成
不适用
A study to compare effects of Tablet Rifaximin alone and in combination with Tablet Norfloxacin for prevention of re-occuring bacterial infection of abdominal fluid and brain function abnormality due to liver disease.CTRI/2021/09/036321Pt BD Sharma PGIMS Rohtak49
招募中
3 期
The effect of rifaximin in IBSIrritable bowel syndrome.Irritable bowel syndromeIRCT20221211056775N1Arak University of Medical Sciences60